These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 11361462

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Immunological and virological activity of zalcitabine and zidovudine in combination in HIV-positive people with CD4 cell counts of between 200-500 cells/mm3.
    Ibáñez A, Peraire J, Arnó A, Gutiérrez C, Cervantes M, Colomer J, Villalonga C, Camafort M, Ruiz L, Balaguer M, Vidal F, Richart C, Clotet B.
    Antivir Ther; 1997 Apr; 2(2):105-11. PubMed ID: 11322274
    [Abstract] [Full Text] [Related]

  • 3. Viral load, viral phenotype modification, zidovudine susceptibility and reverse transcriptase mutations during the first 6 months of zidovudine monotherapy in HIV-1-infected people.
    Rusconi S, De Pasquale MP, Mainini F, Bulgheroni E, Kurtagic S, Gori A, Violin M, Zanchetta N, Moroni M, Balotta C, Galli M.
    Antivir Ther; 1996 Dec; 1(4):211-9. PubMed ID: 11324823
    [Abstract] [Full Text] [Related]

  • 4. Viraemia and p24 antigenaemia are independent risk factors for the emergency of a zidovudine-resistant genotype in nucleoside analogue-treated HIV-1 infection.
    Relimpio F, Rey C, Pineda JA, Leal M, Caruz A, Sánchez-Quijano A, Lissen E.
    Antivir Ther; 1997 Apr; 2(2):99-104. PubMed ID: 11322281
    [Abstract] [Full Text] [Related]

  • 5. Markers of response to zidovudine monotherapy among treated HIV seroconverters. Italian Seroconversion Study.
    Rezza G, Galai N, Pezzotti P, Vlahov D, Graham NM, Viale P, Angarano G.
    Antivir Ther; 1997 Jul; 2(3):167-74. PubMed ID: 11322271
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Maternal immune responses and risk of infant infection with HIV-1 after a short course Zidovudine in a cohort of HIV-1 infected pregnant women in rural Kenya.
    Makokha EP, Songok EM, Orago AA, Koech DK, Chemtai AK, Kobayashi N, Mpoke S, Tukei PM, Andayi FA, Lihana RW, Adungo NI, Vulule JM.
    East Afr Med J; 2002 Nov; 79(11):567-73. PubMed ID: 12630488
    [Abstract] [Full Text] [Related]

  • 11. Intrapartum zidovudine infusion alone failed to reduce both maternal HIV-1 viral load and HIV-1 infection in infant.
    Limpongsanurak S, Thaithumyanon P, Thisyakorn U, Ruxrungtham K, Chaithongwongwatthana S, Kongsin P, Tarounotai U, Chantheptaewan N, Triratwerapong T, Ubolyam S, Phanuphak P.
    J Med Assoc Thai; 2001 May; 84(5):611-6. PubMed ID: 11560207
    [Abstract] [Full Text] [Related]

  • 12. Genotypic resistance tests for the management of the HIV-infected pregnant woman.
    Bassetti D, Cargnel A.
    Scand J Infect Dis Suppl; 2003 May; 106():70-4. PubMed ID: 15000589
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Vertical transmission research at the Retrovirus Conference.
    Cadman J.
    GMHC Treat Issues; 1998 Mar; 12(3):10-2. PubMed ID: 11365391
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Immune restoration in HIV-positive, antiretroviral-naive patients after 1 year of zidovudine/lamivudine plus nelfinavir or nevirapine.
    Plana M, Ferrer E, Martínez C, Podzamczer D, García F, Maleno MJ, Barceló JJ, García A, Barberá MJ, Lacarcel M, Miró JM, Gallart T, Gatell JM.
    Antivir Ther; 2004 Apr; 9(2):197-204. PubMed ID: 15134181
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Viral load affects risk for perinatal HIV transmission.
    WORLD; 1999 Sep; (No 101):6. PubMed ID: 11366949
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.